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ABSTRACT
The Ets-1 transcription factor plays an important role in various physiological and pathologi-
cal processes. These diverse roles of Ets-1 are likely to depend on its interaction proteins. We
have previously showed that Ets-1 interacted with DNA-dependent protein kinase (DNA-PK)
complex including its regulatory subunits, Ku70 and Ku86 and with poly (ADP-ribose) poly-
merase-1 (PARP-1). In this study, the binding domains for the interaction between Ets-1 and
these proteins were reported. We demonstrated that the interaction of Ets-1 with DNA-PK
was mediated through the Ku70 subunit and was mapped to the C-terminal region of Ets-1
and the C-terminal part of Ku70 including SAP domain. The interactive domains between Ets-
1 and PARP-1 have been mapped to the C-terminal region of Ets-1 and the BRCA1 carboxy-
terminal (BRCT) domain of PARP-1. The results presented in this study may advance our
understanding of the functional link between Ets-1 and its interaction partners, DNA-PK and
PARP-1.
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interaction domains
Ets-1 is the founding member of the Ets family char-
acterized by a well-conserved DNA binding domain
(ETS domain). It regulates gene expression by bind-
ing to speciﬁc DNA elements, called ETS-binding
sites, found in the promoters of its target genes [1].
By binding to these elements, Ets-1 activates the
transcription of various genes involved in numerous
cellular mechanisms, including angiogenesis, apopto-
sis, and tumour invasion [2]. Human full-length Ets-1
can be subdivided structurally and functionally into
diﬀerent domains. Two inhibitory domains ﬂank and
interact with the ETS domain and inhibit its DNA
binding [3]. The N-terminal inhibitory domain
belongs to the exon VII-encoded region, a target of
calcium mediated-phosphorylation [4] and of cas-
pase-3-mediated cleavage [5]. Ets-1 harbors also a
transactivation domain in the middle portion of the
protein [6] and a Pointed domain in the N-terminus
of the protein which is involved in protein-protein
interaction [7].
Ets-1 activity is modulated by interactions with a
number of factors. Most proteins that directly contact
Ets-1 bind to the ETS domain. Others associate with
the exon VII-encoded region, the Pointed domain or
the transactivation domain [2]. In a search for addi-
tional interaction partners that might regulate Ets-1
functions, we previously puriﬁed Ets-1−bound pro-
teins using a streptavidin pull-down assay with bioti-
nylated Ets-1, which we have developed [8]. With this
strategy, we have demonstrated an interaction
between Ets-1 and two DNA repair proteins, DNA-
PK [9] and PARP-1 [10]. DNA-PK is a nuclear ser-
ine/threonine protein kinase composed of a catalytic
subunit, DNA-PKcs, and two regulatory subunits,
Ku86 and Ku70. DNA-PK is implicated in a variety
of cellular processes, including the repair of double-
stranded DNA breaks, V(D)J recombination, telo-
mere maintenance and transcriptional regulation
[11]. The interaction of DNA-PK with Ets-1 causes
its phosphorylation even in the absence of DNA.
Although DNA was originally shown to be a potent
activator of DNA-PK [12], we and others have indi-
cated that protein interactions may be another, more
important mechanism for the activation of DNA-PK
kinase activity [9,13,14].
In addition to DNA-PK subunits, another pro-
tein was found in the Ets-1-interacting complex,
corresponding to PARP-1 [10]. PARP-1 is an abun-
dant and ubiquitous nuclear protein that catalyses
poly(ADP-ribosyl)ation (PARylation) by using
NAD+ as substrate to synthesize branched poly
(ADP-ribose) polymers on target proteins. PARP-1
plays diverse roles in many molecular and cellular
processes, including DNA damage detection and
repair, chromatin modiﬁcation and transcriptional
regulation [15,16]. Ets-1 activates, by direct inter-
action, the catalytic activity of PARP-1 and is then
PARylated in a DNA-independent manner. Under
catalytic inhibition of PARP-1, Ets-1 transcriptional
activity is enhanced which correlates with Ets-1
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proteins accumulation in cell nuclei and an
increase in DNA damage that leads to cancer cell
death [10].
In order to better understand the functional con-
sequences of the interactions between Ets-1 and its
protein partners, DNA-PK and PARP1, and essen-
tially how Ets-1 can stimulate their activity, we set out
to identify the DNA-PK subunit that physically inter-
acts with Ets-1 and the regions of their interaction
and then we characterize the domains of Ets-1 and
PARP-1 required for their interaction. Collectively,
these results establish the regions important for the
Ets-1/DNA-PK and Ets-1/PARP-1 interactions, pro-
viding mechanistic insights into the better under-
standing the physiological roles of Ets-1 and the
interacting factor.
Materials and methods
Expression vector construction
The construction of bacterial expression vectors con-
taining the cDNA sequences of human Ets-1 p51, Ets-
1 p27 and N-terminal deletion mutant ΔN331 have
been previously described [17,18]. The construction of
pTyb2 vector expressing human Ets-1 p51 fused to a
biotin tag has been previously described [8]. pGEX-
2TK vectors expressing human full-length Ku70 and
Ku80 fused to a GST as well as deletion mutant con-
structions of GST-Ku70 were kindly provided by
Professor S. P. Jackson (University of Cambridge,
UK) [19]. pET32a-His-PARP-124 and pET32a-His-
PARP-189 vectors, expressing the caspase cleavage pro-
ducts of PARP-1 with hexahistidine tag (His), were
generously provided by Professor M. S. Satoh (Laval
University, Canada) [20]. To produce BRCT domain
of PARP-1 fused to a GST tag, the sequence coding
amino acids 378–479 of PARP-1 was obtained by PCR
ampliﬁcation, using the following primers: 5ʹ-CAGT
AGGGATCCGCTGCTGTGAACTCCTCTGC-3ʹ and
5ʹ-GTCAACGAATTCGGACAAGATGTGCGCTAAG
A-3ʹ. The PCR product was then cloned between the
BamHI and EcoRI restriction sites in a pGEX-2TK (GE
Healthcare®) prokaryotic expression vector. Constructs
were checked for nucleotide sequence.
Expression and puriﬁcation of untagged and
biotinylated recombinant Ets-1
Proteins Expression and puriﬁcation of Ets-1, Ets-1-
ΔN331 and Ets-1 p27 were carried out according to
[17,18], by using the T7 Impact System (New
England Biolabs®). Biotinylated Ets-1 protein was
produced and puriﬁed as described previously [8],
using the principle of the T7-ImpactTM System
adapted to induce biotinylation.
Expression and puriﬁcation of GST-fusion
proteins and Histidine-tagged (His) proteins
The expression plasmids pGEX-2TK and pET32a-6His
were transformed into E. coli (BL21-(DE3)-pLysS)
cells. E. coli cells were grown in 50 mL Luria-Bertani
(LB) medium containing 50 µg/mL ampicillin and
0.5% glucose at 30°C under shaken until the cells
reached a turbidity value of 1 at OD600. 50 ml LB
medium containing 50 µg/ml ampicillin, 0.5% glucose
and 2.5 µg/mL vitamin B1 was added and cells con-
tinued to grow at 30°C until they reached exponential
phase. Cells were then harvested by centrifugation at
4000g for 10 min and resuspended in 200 ml of LB
medium containing 50 µg/mL ampicillin, 2.5 µg/mL
vitamin B1 and 0.3 mM isopropyl-b-D-thiogalactopyr-
anoside (IPTG). The culture was incubated at 30°C
and shaken for 16 hours. The culture was then har-
vested and the pellet was washed with phosphate-buf-
fered saline (PBS) solution and suspended in 20 mL of
lysis buﬀer (50 mM Tris pH 8, 150 mM NaCl, 1 mM
EDTA, CompleteTM protease inhibitor cocktail (Roche
Molecular Biochemicals) and 20 µg/mL DNase I
(Roche)). Bacteria were lysed with EmulsiFlex-C3
(Avestin®) according to the manufacturer’s instruc-
tions. GST and GST fusion proteins were aﬃnity pur-
iﬁed with glutathione-sepharose beads (GST-bindTM
Resin, Novagen®) for 16 h at 4°C and under constant
rotation. The column was washed and then stored at
4°C. For His-tagged proteins, they puriﬁed in sephar-
ose-nickel beads (His CatchTM, Bioline®) for 16 h at 4°
C and under constant rotation. Beads were watched
and eluted with 30 mM imidazol (Sigma-Aldrich®).
GST pull-down assays
Glutathione-sepharose beads (20 µL) coupled with
the puriﬁed GST proteins were blocked by incubating
for 30 min at 4°C in PBS with 17 mg/mL bovine
serum albumin (BSA) (Sigma–Aldrich®). Ets-1
(1 µg), Ets-1 p27 (500 ng) or Ets-1-ΔN331 (250 ng)
proteins were incubated with the prepared glu-
tathione-agarose beads for 1 hour at 4°C under con-
stant rotation. After washing the beads three times
with buﬀer containing 50 mM Tris pH 8; 150 mM
NaCl; 0,1 mM EDTA; 0,5% Igepal and 0,5% Triton
X-100, proteins bound to the beads were eluted by
boiling for 5 min in Laemmli buﬀer (50 mM Tris pH
6.8; 2% SDS; 5% β-mercaptoethanol; 10% glycerol;
0,1% bromophenol blue).
Sterptavidin pull-down assays
Streptavidin sepharoseTM beads (Amersham
Biosciences, GE Healthcare, Velizy-Villacoublay,
France) (30 mL) were washed with PBS and blocked
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by incubating for 1 h at 4°C in PBS with 1 mg/mL
BSA. Biotinylated full-length Ets-1 protein (5 mg)
was incubated with the prepared streptavidin
sepharoseTM beads for 30 min at 4°C under constant
rotation. The Ets-1 loaded beads were then incubated
for 1 h at 4°C with 1 µg of recombinant PARP-1
protein (Trevigen, Gaithersburg, MD, USA), 800 ng
of 6His-PAPR-189 or 220 ng of 6His-PARP-124. After
extensive washing, bound proteins were eluted by
boiling for 5 min in Laemmli buﬀer and analysed
by Western blot.
Western blot analyses
Western blot analyses were performed according to
[5]. Primary antibodies used were C-20 anti-Ets-1,
H-250 anti-PARP-1 and H-15 anti-poly-His from
Santa Cruz Biotechnology (Heidelberg, Germany).
Results
Ets-1 interacts with Ku heterodimer via the
C-terminal end containing the SAP domain of
Ku70
Based on our previous study identifying DNA-PK
components as novel proteins that associate in a
complex with Ets-1 in vitro and in cells [9], and
knowing that regulatory subunits Ku70 and Ku86
often interact with proteins that regulate DNA-PK
kinase activity [13,14], in vitro GST pull-down assay
was carried out to compare the potential direct inter-
actions of Ku subunits with Ets-1. GST, GST-Ku70
and GST-Ku86 fusion proteins were expressed in E.
coli and puriﬁed on glutathione-sepharose beads. As a
binding partner, recombinant Ets-1 was expressed
and puriﬁed using the T7 Impact System.
Interestingly, as shown in Figure 1(a), Ets-1 inter-
acted with Ku70 (lane 2), but failed to interact with
Ku86 (lane 3). These data conﬁrm that Ets-1 associ-
ates with the DNA-PK through direct interaction
with the Ku70 subunit.
The interaction domains of Ets-1 and Ku70 were
further mapped with a set of deletion mutants of
Ku70 fused to GST (ΔN343, ΔN431, ΔN469, ΔN524
and ΔC326) (Figure 1(b), left panel) using GST-pull
down assay. The full length Ets-1 interacted with all
Ku70 N-terminal deletions that retained the
C-terminal from amino acid 524–609 (Figure 1(b);
right panel; lanes 2–5), but failed to interact with
Ku70 that lacked the C-terminal beyond amino acid
326 (Figure 1(b); right panel; lane 6), indicating that
the C-terminal end of Ku70 is required for Ets-1
interaction. Thus, the smallest peptide of Ku70
shown to interact with Ets-1 was amino acids
524–609 located at the C-terminal part including
SAP domain (574–609), a well-known DNA-binding
motif (named after the three proteins that contain
SAF-A/B, Acinus and PIAS motif).
A C-terminal region of Ets-1 interacts with the
C-terminal end containing the SAP domain of
Ku70
Our previous work showed that besides the full-
length form of Ets-1, its two alternatively spliced iso-
forms, Ets-1 p42 and Ets-1 p27, interact also with
DNA-PK [9]. Given that the C-terminal region, con-
sisting of the ETS domain and the C-terminal
Figure 1. Ets-1 full-length interacts with Ku heterodimer through the C-terminal SAP domain of K70. (A) GST-Ku70, GST-Ku86 or
GST alone as a negative control were expressed in E. coli and puriﬁed with Glutathione-Sepharose beads. Puriﬁed proteins (on
beads) were incubated with full-length untagged Ets-1 (1 µg), which was bacterially expressed using the T7 Impact System.
After 1h, the beads were washed, and the bound fractions were separated by SDS-PAGE and subjected to Western blot analysis
using a C-20 anti-Ets-1 antibody. (B) Schematic diagrams depict the diﬀerent GST-Ku70 constructs used in the domain-mapping
experiments. GST-Ku70 derivatives were produced, as described in section (A) above, and then incubated with Ets-1 protein. The
bound proteins were separated by SDS-PAGE and subjected to Western blot analysis using a C-20 anti-Ets-1 antibody.
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inhibitory domain, is a common region shared
between the three Ets-1 isoforms [18,21], we suggest
that Ku70 interacts with this region of Ets-1 protein.
To test that, C-terminal deletion mutant ΔN331
(Figure 2, top panel) was produced in E. coli and
subjected to GST pull-down assay using GST-Ku70
ΔN469, GST-Ku70 ΔN524 and GST-Ku70 ΔC326. As
shown in Figure 2, Ets-1 Δ331 was pulled down by
the interaction with GST-Ku70 ΔN469 and GST-
Ku70 ΔN524 fusion proteins (Figure 2; lanes 2 and
3), whereas no interaction was noted with GST- Ku70
ΔC326 (Figure 2; lane 4). This result coincides with
the GST pull-down assay with full-length Ets-1 data
indicating that the binding site of Ets-1 to the Ku70
SAP domain was at the C-terminal part including the
ETS domain.
A c-terminal region of Ets-1 interacts with PARP-1
via the BRCT domain
We previously demonstrated that PARP-1 speciﬁ-
cally and directly interacts with Ets-1 [10]. To iden-
tify the regions of PARP-1 that interact with Ets-1,
we used two polyhistidine-tagged deletion mutants
of PARP-1 corresponding to its cleavage products
under apoptotic conditions: a 24 kDa N-terminal
fragment with zinc ﬁnger (ZF) motifs 1 and 2 (ZF1
and ZF2) (PARP-124) and an 89 kDa C-terminal
fragment with ZF3 motif, an automodiﬁcation
region with BRCT domain, and a catalytic domain
(PARP-189) (Figure 3(a)).These recombinant pro-
teins and the untagged full-length form were incu-
bated with biotinylated Ets-1 immobilized on
streptavidin beads. We conﬁrmed that full-length
PARP-1 interacted with Ets-1 (Figure 3(b-a), lane
2) but not with empty beads (Figure 3(b-a), lane 1).
Furthermore, we found that Ets-1 interacted with
PARP-189 (Figure 3(b-b), lane 2) but not with
PARP-124 (Figure 3(b-b), lane 4). These results indi-
cate that only C-terminal fragment is required for
binding.
Given that BRCT domain is known to be an impor-
tant protein-protein interaction module [22,23], we
hypothesized that this domain might be important
for the interaction between PARP-1 and Ets-1. To
test that, BRCT domain is generated fused to GST
(Figure 3(a)) and then subjected to GST pull-down
assay. The result showed that BRCT domain of
PARP-1 bound the Ets-1 protein (Figure 3(c-a)). A
possible contribution from the other domains of
PARP-189, namely ZF3 motif and catalytic domain,
was not examined and thus cannot be ruled out.
Our previous work showed that Ets-1 p27 isoform
containing the ETS domain surrounded by two inhi-
bitory domains interacts directly with PARP-1 [10]. To
test whether this interaction is mediated by PARP-1
BRCT domain, GST pull-down assay was used. The
result shows that like Ets-1, Ets-1 p27 interacts with
the BRCT domain (Figure 3(c-b)). To further delimit
the interaction zone, we carried out GST pull-down
with GST-BRCT domain and Ets-1 ΔN331. As shown
in Figure 3(c-c), Ets-1 ΔN331 is pulled down with
GST-BRCT. These results indicate that PARP-1
BRCT domain and the Ets-1 C-terminal region con-
taining ETS domain are required for their interaction.
Discussion
In the previous studies, we found that Ets-1 inter-
acted with DNA-PK components [9] and with PARP-
1 [10]. In the present study, we further analyzed how
Ets-1 interacts with these DNA repair proteins and
Figure 2. The interaction of Ets-1with Ku70 is mediated by its C-terminal region including the ETS domain. Interaction
experiment was performed with the GST forms of Ku70 proteins including the C-terminal (GST-ΔN469 and GST-ΔN524) or the
N-terminal (GST-ΔC326) parts of Ku70 and with Ets-1 ΔN331deletion mutant (top panel). After 1h of incubation of Ets-1 ΔN331
(1 µg) with each of GST-Ku70 derivatives (on beads), the collected beads were washed, and re-suspended in Laemmli buﬀer. The
bound fractions were separated by SDS-PAGE and subjected to Western blot analysis using a C-20 anti-Ets-1 antibody directed
against its C-terminal region.
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we found that Ets-1 interacts through its C-terminal
region with DNA-PK via the SAP domain of the
regulatory subunit Ku70 and with PARP-1 through
BRCT domain.
The two Ku subunits show similarity both in
sequence and in topology, each containing three
well organized regions: an N-terminal α/β domain, a
central β-barrel domain, and a subunit-speciﬁc helical
C-terminal arm. The human Ku70 subunit has
C-terminal domain composed of a highly random
and ﬂexible linker (residues 536–560) and a well
structured helix-extended loop-helix fold (residues
574–609), also referred to as the SAP domain [24].
Consistently, Ets-1 interacts with Ku70 but not Ku86
via a SAP domain uniquely found in Ku70. This is
consistent with other study demonstrating the inter-
action of the homeoproteins, Dlx1 and Dlx2, with
Ku70 but not Ku86 through the SAP domain [14].
Ku is a protein that binds DNA in a non-
sequence-speciﬁc manner and regulates DNA-PKcs
catalytic activity. Although DNA was originally
shown as a potent activator of DNA-PKcs, other
studies [14,25] indicate that the multiple protein fac-
tors recruited by the Ku subunit may also serve as
activators to stimulate DNA-PK activity. For
instance, several homeodomain proteins, including
Oct-1, have been shown [14] to interact with Ku70
and enhance DNA-PK phosphorylation. Consistent
Figure 3. Mapping of interaction domains between Ets-1 and PARP-1. (A) Schematic representation of human PARP-1 domain
structure and constructs used in these experiments. Functional domains are indicated, caspase-3 cleavage site is marked with a
head arrow and numbers indicate amino acid positions. (B) Streptavidin beads loaded with biotinylated Ets-1 (Biot-Ets-1) (lane 2,
left panel and lanes 2 and 4, right panel) or unloaded beads (lane 1, left panel and lanes 1 and 3, right panel) were incubated
with full-length PARP-1 (1 µg), His-PARP-189 (800 ng) or His-PARP-124 (220 ng). Bound proteins were resolved by SDS-PAGE and
detected by Western blot (WB) using anti-PARP-1 (left) and anti-His (right) antibodies. Inputs correspond to the amount of
proteins used for the pull-down. (C) GST or GST-BRCT were expressed in E. coli and puriﬁed with Glutathione-Sepharose beads.
Puriﬁed proteins (on beads) were incubated with Ets-1 (1 µg), Ets-1 p27 (500 ng) or Ets-1 ΔN331 (250 ng). Bound proteins were
resolved by SDS-PAGE and detected by Western blot using a C-20 anti-Ets-1 antibody. Lane 1, control with unloaded beads.
INTERACTION DOMAINS OF ETS-1 WITH BOTH KU70 AND PARP-1 1757
with their ﬁnding, Ets-1 interacts with Ku70 but not
Ku86. This interaction may consequently result in
stimulation of DNA-PK in the absence of DNA.
The DNA-independent stimulation of DNA-PK by
direct interaction with Ku70 was also observed in
other proteins such as in thyroid hormone receptor-
binding protein (TRBP) [13]. It appears that although
DNA-PK can be stimulated by DNA ends [12], or by
other kinases [26,27], protein interactions via Ku70
may be another more important but previously less
appreciated mechanism for DNA-PK activation.
In addition to DNA-PK subunits, we have identi-
ﬁed a physical interaction between Ets-1 and PARP-1,
and we have shown that the Ets-1/PARP-1 interac-
tion is important for the PARylation of Ets-1 in a
DNA-independent manner [10]. In this paper, we
further mapped the interacting domains between
Ets-1 and PARP-1. We found that PAPR-1 associates
with Ets-1 through its BRCT domain already
described as platforms for protein-protein interaction
with several partners [22,23].
DNA damage was shown as a potent activator of
PARP-1 [28]. The multiple domains of PARP-1 col-
lapse onto damaged DNA, forming a network of
interdomain contacts that introduce destabilizing
alterations in the catalytic domain leading to an
enhanced rate of poly(ADP-ribose) production [29].
We and others have indicated that protein-protein
interaction may also stimulate PARP-1 activity in
the absence of DNA damage [10,30,31] and that
most of the proteins that are PARylated by PARP-1
interact with the BRCT domain [32,33]. The BRCT
domain is not strictly required for DNA damage-
dependent activity, but its positioning within the
protein will have important implications for how
PARP-1 recruits partner proteins which stimulates
PARP-1 activity in the absence of DNA, and in
turn, PARP-1 PARylates them. It will be interesting
to investigate whether interaction with the BRCT
domain can lead to the same changes observed in
PARP-1 DNA-dependent activation.
In order to better understand Ets-1/Ku70 and Ets-
1/PARP-1 interactions and as the solution structures
of the PARP-1 BRCT domain [34], the Ku70 SAP
domain [35] and the Ets-1 ETS domain [36] were
previously determined, it will be interesting to per-
form studies designed to elucidate these interactions.
Therefore, we can attempt to co-crystallize these
interacting domains in order to determine the essen-
tial contact areas and to determine the structure of
the complexes. Furthermore, due to the existence of
the structural data for each of the domains, it is also
possible to complete this structural approach by
molecular modeling of the complexes. These struc-
tural studies make it possible to identify the residues
essential to these interactions. Moreover, the role of
domain-domain interaction in the functional
relevance of Ets-1/Ku70 and Ets-1/PARP-1 interac-
tions, previously characterized [9,10], need further
study to broaden our understanding of the functional
role of Ets-1 interacting proteins. Nevertheless, we
have demonstrated that the short isoform Ets-1 p27,
containing only the C-terminal region of Ets-1
including the ETS domain, activates both DNA-PK
and PARP-1 by direct interaction and is then phos-
phorylated and PARylated, respectively, in a DNA-
independent manner.
In summary, we have revealed that Ets-1 interacts
through its C-terminal region containing the ETS
domain with the SAP domain of Ku70 and with the
PARP-1 BRCT domain. These observations raise a
number of interesting questions on the physiological
importance of these interactions and the diﬀerent
cross-talks between these proteins. Addressing these
questions will add new insight into the understanding
of the biology of Ets-1.
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